Published in Sci Rep on January 06, 2016
Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding. Int J Nanomedicine (2017) 0.75
Hybrid intraoperative imaging techniques in radioguided surgery: present clinical applications and future outlook. Clin Transl Imaging (2017) 0.75
In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol (2003) 10.76
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med (2011) 7.82
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06
Molecular imaging. Radiology (2001) 5.67
Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol (2006) 3.98
Investigations of avidin and biotin for imaging applications. J Nucl Med (1987) 1.88
Dual-modality imaging: combining anatomy and function. J Nucl Med (2008) 1.72
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nat Med (2005) 1.69
Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. Mol Pharm (2009) 1.41
Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. J Am Chem Soc (2008) 1.38
Pretargeted molecular imaging and radioimmunotherapy. Theranostics (2012) 1.31
Antibodies against metal chelates. Nature (1985) 1.27
Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging. Head Neck (2011) 1.22
In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. J Nucl Med (2003) 1.22
Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label. Bioconjug Chem (2010) 1.20
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts. Mol Cancer Ther (2010) 1.13
Avidin targeting of intraperitoneal tumor xenografts. J Natl Cancer Inst (1998) 1.09
99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression. Bioconjug Chem (2006) 1.07
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model. Radiology (2008) 1.04
Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med (2000) 0.96
99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer. Bioconjug Chem (2008) 0.93
Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging (2005) 0.92
Nuclear inclusions and pseudoinclusions: friends or foes of the surgical pathologist? Int J Surg Pathol (2010) 0.89
Biotin-rich, optically clear nuclei express estrogen receptor-beta: tumors with morules may develop under the influence of estrogen and aberrant beta-catenin expression. Hum Pathol (2004) 0.89
Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy. Invest New Drugs (2011) 0.85
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update. Clin Cancer Res (2007) 0.84
Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody. Nucl Med Biol (2012) 0.81
Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors. Clin Cancer Res (2003) 0.80
Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry. J Drug Target (2010) 0.78